3:47 PM · 14 April 2025

Goldman Sachs shares gain 2.5% after quarterly results 🏛️

Goldman
Stocks
GS.US, Goldman Sachs Group Inc
-
-

Goldman Sachs (GS.US) shares are gaining nearly 2.5% after the financial institution published its results for the first quarter of 2025. The GS board also approved a share buyback program worth up to $40 billion.

The company's Q1 results:

  • Revenue: $15.06 billion (+6% y/y, exceeding expectations of $14.76 billion)
  • Earnings per share: $14.12 (vs. $11.58 y/y)
  • FICC turnover: $4.40 billion (exceeding expectations of $4.47 billion)
  • Equity turnover: $4.19 billion (exceeding expectations of $3.8 billion)
  • Global Banking & Markets: $10.71 billion (+10% y/y, exceeding expectations of $10.42 billion)
  • Investment banking: $1.92 billion (-8.1% y/y, exceeding expectations of $2.03 billion)
  • Consulting: $792 million (-22% YoY, beating expectations at $910m)
  • Net interest income: $2.90bn (beating expectations at $2.28bn)
  • Deposits: $471bn (+8.8% QoQ)
  • Credit loss provision: $287mn (below expectations at $410m)
  • Operating expenses: $9.13bn (+5.4% YoY, in line with expectations)
  • ROE: 16.9% (beating expectations at 14.9%)
  • ROTE: 18% (beating expectations at 16.1%)
  • CET1 ratio: 14.8% (slightly beating expectations at 15%)
  • Book value/share: $344.20 (up from $321.10 y/y)
  • Efficiency ratio: 60.6% (better than expected at 61.6%)
  • Assets under management: $3.17 trillion (+11% y/y, exceeding expectations at $3.15 billion)
  • Net inflows: $24 billion (vs. $15 billion in outflows y/y, exceeding expectations at $34 billion)
  • Loans: $210 billion (beating expectations at $197.6 billion)

 

Source: xStation

10 October 2025, 8:51 PM

Applied Digital accelerates growth. Shares rise by nearly 20%.

10 October 2025, 12:52 PM

DAX: DE40 tries to hold the momentum 📈Brenntag and ArcelorMittal under pressure

9 October 2025, 7:13 PM

Delta Airlines stock lifts off after earnings✈️

9 October 2025, 6:34 PM

Stock of the Week - Super Micro Computer (09.10.2025)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world